Xuedong Wang, Kui Deng, Jing Tao, Juan Zou, Yiting Du, Li Dai. RIPK1 polymorphisms and expression levels: impact on genetic susceptibility and clinical outcome of epithelial ovarian cancer.Cancer cell international. 2023, 23 (1): 290
Christophe Michel Raynaud, Eiman I Ahmed, Ayesha Jabeen, Apryl Sanchez, Shimaa Sherif, Tatiana C Carneiro-Lobo, Amany Awad, Dina Awartani, Adviti Naik, Remy Thomas, Julie Decock, Gabriele Zoppoli, Davide Bedongnetti, Wouter R L Hendrickx. Modulation of SLFN11 induces changes in DNA Damage response in breast cancer.Cancer cell international. 2023, 23 (1): 291
Ganggang Wang, Hao Zhang, Xiaowei Shen, Wenzhi Jin, Xiaoliang Wang, Zhijie Zhou. Characterization of cancer-associated fibroblasts (CAFs) and development of a CAF-based risk model for triple-negative breast cancer.Cancer cell international. 2023, 23 (1): 294
Lucie Heczko, Viktor Hlaváč, Petr Holý, Pavel Dvořák, Václav Liška, Ondřej Vyčítal, Ondřej Fiala, Pavel Souček. Prognostic potential of whole exome sequencing in the clinical management of metachronous colorectal cancer liver metastases.Cancer cell international. 2023, 23 (1): 295
Shan Lu, Ruifeng Duan, Liang Cong, Ying Song. The effects of ARID1A mutation in gastric cancer and its significance for treatment.Cancer cell international. 2023, 23 (1): 296
Jung Eun Lee, Jihye Park, Eun Ju Kim, Yoon Ho Ko, Soon Auck Hong, Seung Ho Yang, Young-Ho Ahn. Noggin contributes to brain metastatic colonization of lung cancer cells.Cancer cell international. 2023, 23 (1): 299